Medicinal Synopsis of Abacavir Sulfate Sulfate, Abarelix, and Abiraterone Acetate Acetate

Wiki Article

These three separate compounds represent diverse applications within current medicine, highlighting the sophistication of pharmaceutical design. Abacavir Sulfate Sulfate, a nucleoside reverse nucleoside inhibitor, is primarily utilized in treating HIV infections. Abarelix Acetate, a peptide, functions as a gonadotropin-releasing GnRH antagonist, showing promise in treating prostate cancer. Finally, Abiraterone Acetate Acetate, a potent CYP17A1 blocker, plays a crucial function in managing metastatic castration-resistant prostate cancer. Their differing structural frameworks dictate their particular mechanisms of action and therapeutic characteristics.

{CASRegistry Numbers for Abacavir Sulfate, Abarelix, and Abiraterone Acetate

Identifying {chemicaldrug substancesentities accurately is essential for research endeavorsinvestigations, regulatory compliance, and consistentreliable communication. Therefore, {assigning unique identifiers is paramount. For {abacavirAbacavir sulfate, the accepted CAS Record Number is 64717-29-8; abarelix carries the CAS Registry Number 53327-35-2; and abiraterone acetate is identified by CAS Record Number 940431-49-3. These codes ensure unambiguous definition in {databasesrepositories and literaturereferences.

Pinpointing Pharmaceutical Substances: Abacavir Sulfate (188062-50-2), Abarelix (183552-38-7), Abiraterone Acetate (154229-18-2)

Precise identification of medication compounds is absolutely essential in assurance and research settings. This paragraph focuses on three specific examples: Abacavir Sulfate, a nucleoside reverse transcriptase inhibitor with the chemical identifier 188062-50-2; Abarelix, a gonadotropin-releasing hormone (GnRH) antagonist, characterized by the registration number 183552-38-7; and Abiraterone Acetate, a steroid synthesis inhibitor bearing the reference 154229-18-2. Accurate spectral data, including mass spectrometry and infrared spectroscopy, are routinely utilized for confirming their presence and purity. Furthermore, sophisticated analytical techniques may be necessary to differentiate these molecules from related substances or impurities, which is particularly important during drug development and manufacturing processes. Proper handling and validation protocols are imperative for each compound to ensure reliable results.

Accurate Chemical Recognition via CAS Registry

The unambiguous determination of pharmaceutical compounds is paramount in research, manufacturing, and regulatory affairs. To ensure clarity and avoid confusion, relying on Chemical Abstracts Service (CAS) identifiers offers a globally recognized method. For example, Abacavir Sulfate, a nucleoside analog reverse transcriptase inhibitor used in HIV treatment, is uniquely identified by its CAS number 64252-05-7. Similarly, Abarelix, a gonadotropin-releasing hormone (GnRH) antagonist, is designated CAS 58092-35-2. Lastly, Abiraterone Acetate, utilized in prostate cancer therapy, carries the CAS number 857346-02-8. Utilizing these specific CAS registry provides certainty regarding the exact chemical entity being discussed, mitigating potential errors in production and assessment.

Drug Information: Abacavir Sulfate, Abarelix HP, and Abiraterone Acetate - Chemical Abstracts Service Details

A comprehensive examination of these three key therapeutic agents necessitates a close look at their respective CAS details. Abacavir Sulfate, a nucleoside reverse transcriptase inhibitor, demonstrates crucial details regarding its structural formula and production process, easily accessed through the CAS registry. Similarly, Abarelix, a gonadotropin-releasing hormone (GnRH) antagonist utilized in prostate cancer treatment, presents vital compound properties and safety characteristics within the Chemical Abstracts Service system. Finally, Abiraterone Acetate, employed in advanced prostate cancer therapy, has its creation and related analytical data meticulously documented within CAS records, facilitating study and quality control efforts. The Chemical Abstracts Service number serves as a unique identifier for each compound, guaranteeing accurate recognition across various scientific areas.

Chemical Abstracts Service Number Relationship: Abacavir Sulfate, Abarelix, Abiraterone Acetate

Understanding the definitive AMORDAFINIL 68693-11-8 identification of pharmaceutical substances is critical, and Registry numbers provide that unique designation. For instance, abacavir sulfate, a nucleoside reverse transcriptase inhibitor used in HIV treatment, has a specific Chemical Abstracts Service number enabling its accurate identification. Similarly, abarelix, a gonadotropin-releasing hormone (GnRH) antagonist employed in addressing prostate cancer, and abiraterone acetate, a steroid inhibitor of testosterone synthesis also used in malignancy treatment, each possess their designated Registry numbers, assuring their clear recognition within scientific literature and medicinal records.

Report this wiki page